US Broker Ratings

Gilead Sciences, Inc. (GILD) Stock Analysis: Navigating Highs with a Resilient Portfolio

Gilead Sciences, Inc. (NASDAQ: GILD), a key player in the healthcare sector, is making waves with its robust portfolio of biopharmaceutical products. With a market capitalization of $189.22 billion, the..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A Promising 31.93% Upside Amid Robust Revenue Growth

IQVIA Holdings, Inc. (NYSE: IQV), a formidable player in the healthcare sector, specifically within the diagnostics and research industry, is capturing the attention of investors with its solid growth trajectory..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 27% Upside Potential in the Healthcare Sector

Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a prominent player in the healthcare sector specializing in drug manufacturing, is capturing investor attention with its robust growth potential and strong analyst backing. With..

Waters Corporation (WAT) Stock Analysis: Healthcare Sector Player with 9.35% Upside Potential

Waters Corporation (NYSE: WAT), a prominent entity in the healthcare sector, specifically within the diagnostics and research industry, has been making significant strides in offering cutting-edge analytical workflow solutions across..

Edwards Lifesciences Corporation (EW) Stock Analysis: A 23.37% Potential Upside in Healthcare Innovation

Edwards Lifesciences Corporation (NYSE: EW), a prominent player in the healthcare sector, is capturing the attention of investors with its robust growth metrics and a promising potential upside of 23.37%...

Insulet Corporation (PODD) Stock Analysis: Exploring 52.79% Potential Upside

Insulet Corporation (NASDAQ: PODD), a prominent player in the medical devices sector, offers a compelling investment outlook for those interested in healthcare innovation. With a market capitalization of $17.03 billion,..

Alnylam Pharmaceuticals (ALNY) Investor Outlook: Unpacking a 46.21% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) remains a standout player in the biotechnology sector, capturing the attention of investors with a market capitalization of $43.35 billion. As a trailblazer in the..

Agilent Technologies, Inc. (A): Investor Outlook with a 30.94% Potential Upside

Agilent Technologies, Inc. (NYSE: A), a pivotal player in the healthcare sector specializing in diagnostics and research, is under the financial spotlight with a current market capitalization of $36.74 billion...

Biogen Inc. (BIIB) Stock Analysis: A Closer Look at Its Growth Potential and Analyst Sentiments

Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector, operates within the highly competitive landscape of general drug manufacturing. With a market capitalization of $29.51 billion, Biogen continues..

Eli Lilly (LLY) Stock Analysis: Strong Revenue Growth and 12.57% Potential Upside

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector, continues to capture investor attention with its impressive market performance and promising growth prospects. With a staggering market..

Solventum Corporation (SOLV) Stock Analysis: Unlocking a 14.25% Potential Upside in Healthcare Innovation

Solventum Corporation (NYSE: SOLV) is gaining attention in the healthcare sector, particularly within the medical instruments and supplies industry. Headquartered in Maplewood, Minnesota, Solventum is a relatively new player in..

Hologic, Inc. (HOLX) Stock Analysis: Navigating a Promising Yet Cautious Investment Landscape

Hologic, Inc. (NASDAQ: HOLX), a key player in the healthcare sector, stands out with its focused efforts on enhancing women’s health through innovative medical instruments and supplies. With a market..

Teva Pharmaceutical Industries (TEVA): Investor Outlook Reveals 6% Potential Upside

Teva Pharmaceutical Industries (NYSE: TEVA), a stalwart in the healthcare sector, operates as a global leader in the specialty and generic drug manufacturing industry. With a market cap of $39.9..

West Pharmaceutical Services (WST) Stock Analysis: Unveiling a 36% Upside Potential in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST) stands out in the healthcare sector with a robust presence in the medical instruments and supplies industry. With a market capitalization of $17.91 billion,..

Becton, Dickinson and Company (BDX) Stock Analysis: A Pillar in Healthcare with a 2% Dividend Yield and Strategic Growth Prospects

Becton, Dickinson and Company (NYSE: BDX) has long been a cornerstone in the healthcare industry, renowned for its robust portfolio of medical supplies, devices, laboratory equipment, and diagnostic products. With..

STERIS plc (Ireland) (STE)

⚠️ No article content returned.

..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Exploring a Potential 14.27% Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) continues to hold a significant position in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $17.82 billion, the..

Alcon Inc. (ALC) Stock Analysis: A Prescription for 16.45% Potential Upside

Alcon Inc. (ALC), a prominent player in the healthcare sector, specializing in medical instruments and supplies, has captured the attention of investors with its promising financial metrics and strategic positioning..

Novartis AG (NVS) Stock Analysis: A Look at the Healthcare Giant’s Performance and Potential

Novartis AG (NVS), a stalwart in the healthcare sector, is commanding attention with its current market dynamics and expansive pharmaceutical portfolio. Headquartered in Basel, Switzerland, this drug manufacturing titan boasts..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Unveiling a 25% Upside Potential in the Healthcare Sector

Intuitive Surgical, Inc. (ISRG), a titan in the healthcare sector, stands at the forefront of medical innovation with its cutting-edge technology. Renowned for its da Vinci Surgical System, this Sunnyvale,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds